alzheimers disease clinical trial

What is Alzheimer’s Disease

Alzheimer’s disease is a progressive disease that destroys memory and other important mental functions.

It’s the most common cause of dementia — a group of brain disorders that results in the loss of intellectual and social skills. These changes are severe enough to interfere with day-to-day life.

The quality of life of the family of someone suffering from Alzheimer’s is often challenging as they care for their loved one.

In Alzheimer’s disease, the connections between brain cells and the brain cells themselves degenerate and die, causing a steady decline in memory and mental function.

Alzheimer's Disease Clinical Trial

Eligibility

Participate

Please review the tabs below if you are interested in joining this trial study to see if you are eligible, our location, and how to contact us to schedule a screening.

Overview

If you suffer from Alzheimer’s disease or care for someone that does, then you know that memory loss is only one symptom of this debilitating disease that affects four million Americans and their families.

A research study testing the effectiveness of an investigational medication for treating mild to moderate Alzheimer’s is now underway at Richmond Behavioral Associates in Staten Island.

Qualification Criteria

  • The participant must have a confirmed diagnosis of Alzheimer’s Disease
  • The participant must have a caregiver who can accompany them to all study appointments

Study Participants Will Receive

  • All study-related evaluations, physical exams and follow up visits at no cost
  • All study medication at no cost
  • Possible compensation for their time and travel

Health insurance is not needed to participate

Richmond Behavioral Associates

4349 Hylan Boulevard

Staten Island, NY 10312

Call to schedule a screening 718-317-5522 ext 3

Call

Call to schedule a screening 718-317-5522 ext 3

Or

Email us to schedule a screening

A research coordinator will discretely contact you within 48 hours.

Other Clinical Trials

  • Agitation Clinical Trial

    Agitation in patients with Alzheimer’s disease can lead to outburst, confusion, and difficulty living at home. There are better treatments on the horizon.